| Ytd | 11.25% | |
| 1y | -5.71% |
| Open | 100.20 | Prev Close | 100.91 | Low | 99.54 | High | 100.28 | Mkt Cap | 19.08B |
| Vol | 1.30M | Avg Vol | 2.25M | EPS | 4.12 | P/E | 24.28 | Forward P/E | 11.03 |
| Beta | 0.46 | Short Ratio | 3.34 | Inst. Own | 111.39% | Dividend | 0.96 | Div Yield | 0.95 |
| Ex Div Date | 06-25 | Earning | 11-05 | 50-d Avg | 93.89 | 200-d Avg | 91.12 | 1yr Est | 107.57 |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a glob
ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, tho
Zimmer Biomet (NYSE: ZBH) reported second-quarter 2026 net sales of $2.177 billion, up 4.8% on a rep
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold
Zimmer Biomet NYSE: ZBH reported second-quarter 2026 net sales of $2.177 billion, up 4.8% on a repor
Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hol
RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform an
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the pr
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript
ZBH beats second-quarter earnings and revenue estimates, raises its 2026 outlook and gains in pre-ma
While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed i
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus
Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.40-$8.55 to $8.47-$8.59 vs
Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $2.07 per share which beat the anal
Second quarter net sales of $2.177 billion increased 4.8% on a reported basis, 4.7% on a constant cu
Can Zimmer Biomet, Charles River Laboratories and Bio-Techne meet earnings expectations? See the Med
ZBH heads into Q2 earnings with expectations of modest revenue growth as investors watch demand tren
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise doub
Gabelli Funds LLC grew its position in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 13.0% in the firs
ABN Amro Investment Solutions lessened its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
D.A. Davidson and CO. boosted its stake in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 170.3% during
WARSAW, Ind., July 14, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a glob
WARSAW, Ind., July 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a glob
BMO Capital analyst Vik Chopra initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Mar
Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperf
Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and l
Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that
Tech stocks slide as OpenAI's user growth miss reignites AI capex skepticism, while oil rallies
Top Wall Street analysts changed outlook on top names, downgrading ZBH, GOSS, TRI, PCG, and BOX. See
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investo
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical t
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like X
It's a mixed session on Wall Street, with major indices struggling for direction as investors ho
License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS MarketsAgree